Description
BSE announces the upcoming listing and admission to trading of equity shares of Accretion Nutraveda Limited on the SME segment.
Summary
BSE has announced that equity shares of Accretion Nutraveda Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544694, symbol ANL, and ISIN INE1KVQ01019. The exact date of listing and additional security details will be communicated through a separate notice.
Key Points
- Company Name: Accretion Nutraveda Limited
- Scrip Code: 544694
- Trading Symbol: ANL
- ISIN: INE1KVQ01019
- Segment: SME
- Listing date to be announced separately
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
Trading members are informed to note the listing details. No specific compliance actions required at this stage pending the final listing date announcement.
Important Dates
- Notice Date: February 3, 2026
- Listing Date: To be informed through separate notice
Impact Assessment
This is a routine listing announcement for an SME company. Impact is limited to trading members who need to be aware of the new security for future trading. The listing will add one more equity to the BSE SME platform. Broader market impact is minimal as this is a standard administrative notification pending the actual listing date.
Impact Justification
Routine listing announcement for a single SME company. Date of listing to be notified separately. Limited immediate market impact.